1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Switzerland Pharmaceuticals and Healthcare Report Q3 2016

Switzerland Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 72 pages

Includes 3 FREE quarterly updates

BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The pensionable population proportion is high and growing, andthis will translate into greater demand for drugs. Furthermore, the country's highly developedinfrastructure means that access to healthcare is easy, further supporting the consumption ofmedicines. Switzerland has one of the most expensive healthcare systems in the world, only behind the US.

Headline Expenditure Projections

- Pharmaceuticals: CHF7.07bn (USD7.34bn) in 2015 to CHF7.09bn (USD6.89bn) in 2016; +0.29% inlocal currency terms and -6.1% in US dollar terms.

- Healthcare: CHF73.62bn (USD76.47bn) in 2015 to CHF75.39bn (USD73.33bn) in 2016; +2.4% growthin local currency terms and -4.1% in US dollar terms.

Table Of Contents

Switzerland Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Switzerland 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020) 23
OTC Medicine Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Switzerland 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Switzerland 2014-2020) 27
Industry Risk/Reward Index 28
Western Europe Risk/Reward Index 28
Switzerland Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 35
Pricing Regime 35
Reimbursement Regime 36
Market Overview 38
Healthcare Sector 39
Table: 2013 and 2014: Health Insurance Premiums 40
Table: Healthcare Resources (Switzerland 2010-2015) 41
Table: Healthcare Personnel (Switzerland 2010-2015) 41
Table: Healthcare Activity (Switzerland 2010-2015) 42
Research and Development 42
Clinical Trials 43
Epidemiology 44
Competitive Landscape 47
Research-Based Industry 47
Table: Multinational Market Activity 48
Generic Drugmakers 49
Pharmaceutical Retail Sector 49
Company Profile 50
Novartis 50
Roche 55
GlaxoSmithKline 59
Demographic Forecast 61
Table: Population Headline Indicators (Switzerland 1990-2025) 62
Table: Key Population Ratios (Switzerland 1990-2025) 62
Table: Urban/Rural Population and Life Expectancy (Switzerland 1990-2025) 63
Table: Population By Age Group (Switzerland 1990-2025) 63
Table: Population By Age Group % (Switzerland 1990-2025) 64
Glossary 66
Methodology 68
Pharmaceutical Expenditure Forecast Model 68
Healthcare Expenditure Forecast Model 68
Notes On Methodology 69
Risk/Reward Index Methodology 70
Index Overview 71
Table: Pharmaceutical Risk/Reward Index Indicators 71
Indicator Weightings 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.